Literature DB >> 16232028

Increase in international normalized ratio after smoking cessation in a patient receiving warfarin.

Mark Evans1, Geoffrey M Lewis.   

Abstract

A 58-year-old man who was taking warfarin at a stable dosage was admitted to the hospital with a diagnosis of bacterial meningitis. Although he had previously been a smoker, after this admission, he decided to give up smoking. He was continued on his previous warfarin maintenance dosage when discharged, and his international normalized ratio (INR) soon began to climb substantially. When questioned, the patient reported no diet or lifestyle changes other than his smoking cessation. The patient's INR was stabilized at a warfarin dosage 23% lower than the maintenance dosage before he stopped smoking. This case report illustrates the potential for an interaction between warfarin and cigarette smoking and further suggests that the effect could be significant if a patient starts or stops smoking during warfarin therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16232028     DOI: 10.1592/phco.2005.25.11.1656

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

Review 1.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Effect of patient-specific factors on weekly warfarin dose.

Authors:  Heather P Whitley; Joli D Fermo; Elinor Cg Chumney; Walter Adam Brzezinski
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

Review 3.  Therapeutic drug monitoring in a developing nation: a clinical guide.

Authors:  Ndubuisi Nwobodo
Journal:  JRSM Open       Date:  2014-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.